1-8 of 8
Wenbing Duan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olverembatinib (HQP1351) Combined with Chemotherapy Is an Effective and Safe Treatment in Patients with Philadelphia Chromosome-Positive (Ph + ) Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia in Lymphoid Blast Phase (CML-LBP) That Failed TKI-Based Regimens

Zongru Li, Zhao Ting, Lijuan Hu, Wenbing Duan, Qian Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5895.
https://doi.org/10.1182/blood-2023-185471
Published: 2023
Journal Articles

Only FLT3-ITD Mutation Did Not Have a Deleterious Effect on Acute Myeloid Leukemia Patients with NPM1 Mutation, but Concomitant with DNMT3A Mutation or a＜3log Reduction of MRD2 Predicted Poor Survival

Wenbing Duan, Jinsong Jia, Jing Wang, Xiaohong Liu, Lizhong Gong, WenJing Yu, Xiaolu Zhu, Zhao Ting, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Yu Wang, Hongxia Shi, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4309.
https://doi.org/10.1182/blood-2023-184769
Published: 2023
Journal Articles

Both the Subtypes of Kit Mutation and Minimal Residual Disease Are Associated with Prognosis in Core Banding Factor Acute Myeloid Leukemia

Wenbing Duan, Xiaohong Liu, Jinsong JIA, MDPhD, Jing Wang, MD, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, Lanping Xu, Xiaosu Zhao, PhD, Yazhen Qin, Hongxia Shi, Yingjun Chang, Xiaojun Huang, Hao Jiang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-141905
Published: 2020
Journal Articles

Interferon-a-2b As a Maintenance Therapy Significantly Improves Disease-Free Survival in Patients with Low-Risk Acute Myeloid Leukemia

Xiaohong Liu, Wenbing Duan, Jing Wang, MD, Jinsong Jia, Lizhong Gong, Shen-ye Lu, MD, Xiaosu Zhao, PhD, Ying-Jun Chang, Yue-Yun Lai, Hongxia Shi, Yu Wang, Chenhua Yan, Xiaojun Huang, MD, Hao Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3823.
https://doi.org/10.1182/blood-2019-128505
Published: 2019
Journal Articles

The Lost or Absence of MRD<0.1% at Any Time after 2 Cycles of Consolidation Chemotherapy in CBFB-MYH11-Positive Acute Myeloid Leukemia Indicates Poor Prognosis

Wenbing Duan, Jinsong Jia, Jing Wang, MD, Xiaohong Liu, Lizhong Gong, Qian Jiang, MD, Ting Zhao, Yu Wang, Xiaohui Zhang, MD, Lanping Xu, Yanrong Liu, Yazhen Qin, Xiaojun Huang, MD, Hao Jiang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2616.
https://doi.org/10.1182/blood-2019-126938
Published: 2019
Journal Articles

Clinical Features and Early Effect in EVI1 Positive Acute Myeloid Lleukemia

Wenbing Duan, Lizhong Gong, Jinsong Jia, Honghu Zhu, MD, Xiaosu Zhao, Qian Jiang, PhD, Ting Zhao, Ya-Zhen Qin, Xiaojun Huang, MD, Hao Jiang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5026.
https://doi.org/10.1182/blood.V130.Suppl_1.5026.5026
Published: 2017
Journal Articles

Effect of Knockdown of CD44 Expression by shRNA On Biologicalfeatures of Activated B-Cell-Like Diffuse Large B Cell Lymphoma Cell Line

Ru Feng, M.D., Xiaolei Wei, Ph.D, Wenbing Duan, M.D., Fen Huang, M.D., J. Jessica Yu, B. Hilda Ye, PhD
Journal: Blood
Blood (2012) 120 (21): 5080.
https://doi.org/10.1182/blood.V120.21.5080.5080
Published: 2012
Journal Articles

The Significance of CD44ICD in Difuse Large B- Cell Lymphoma Cell Line SUDHL2 and the Preliminary Study On the Mechanism

Ru Feng, M.D., Wenbing Duan, M.D., Dayan Chen, M.D., Xiaolei Wei, Ph.D, Yongqiang Wei, M.D. Ph.D, Fen Huang, M.D., J. Jessica Yu, B. Hilda Ye, PhD
Journal: Blood
Blood (2012) 120 (21): 5087.
https://doi.org/10.1182/blood.V120.21.5087.5087
Published: 2012